Joel E. Gallant, MD, MPH, reports on first-line therapy by reviewing posters on this subject, including important updates on GS934, ALERT, BMS-089, and GS903E. (9 minutes)

Richard E. Chaisson, MD, discusses new data presented on TB and HIV including such topics as immune reconstitution inflammatory syndrome and combining TB and HIV therapy. (13 minutes)

David A. Cooper, MD, DSc, remarks on presentations addressing the pros and cons of early treatment, both in the developed and developing world. (9 minutes)

Joel E. Gallant, MD, MPH, reviews new cohort data that may strengthen the growing argument for earlier therapy. (7 minutes)

Eric S. Daar, MD, summarizes results of several ongoing clinical trials of antiretroviral therapy in both treatment-naive and treatment-experienced patients. (9 minutes)

Hoosen Coovadia, MBBS, MD, reviews data investigating strategies to decrease transmission by breastfeeding of HIV from mothers who are HIV infected to their infants. (5 minutes)

Daniel R. Kuritzkes, MD, summarizes emerging data from presentations about resistance to newer drugs such as CCR5 antagonists, etravirine, and integrase inhibitors. (11 minutes)

Brian Gazzard, MA, MD, FRCP, describes data from several posters on the treatment of ARV-experienced patients. (6 minutes)

Vicente Soriano, MD, PhD, provides an overview of several presentations that address the treatment of HIV and hepatitis coinfection. (10 minutes)

Thomas Quinn, MD, MSc, describes the results of the final reports of the 3 large circumcision trials and the effect of this intervention on preventing HIV acquisition in males. (17 minutes)

Andrew Carr, MD, discusses the long-awaited results of the PREDICT-1 trial as well as other data presented in an oral session on adverse events of ART. (8 minutes)